CD28 and rheumatoid arthritis: In the RA cohort, surface RANKL was significantly higher in CD4+CD28− T-cells compared to CD28+ T-cells [3.7% (0.2–57.9) vs. 2.4% (0.2–35.4), p = 0.001, Figure 2A].